DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,294 filers reported holding DANAHER CORPORATION in Q4 2018. The put-call ratio across all filers is 1.15 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $762,908 | +3.0% | 3,075 | -0.3% | 0.19% | +6.7% |
Q2 2023 | $740,400 | -4.5% | 3,085 | +0.3% | 0.18% | -7.7% |
Q1 2023 | $775,023 | -5.0% | 3,075 | 0.0% | 0.19% | -7.6% |
Q4 2022 | $816,166 | -5.1% | 3,075 | -7.7% | 0.21% | -13.2% |
Q3 2022 | $860,000 | -2.2% | 3,331 | -3.9% | 0.24% | +3.4% |
Q2 2022 | $879,000 | +24.3% | 3,465 | +43.8% | 0.23% | +42.7% |
Q1 2022 | $707,000 | +71.2% | 2,410 | +91.9% | 0.16% | +64.0% |
Q4 2021 | $413,000 | +9.5% | 1,256 | +1.3% | 0.10% | -4.8% |
Q3 2021 | $377,000 | +13.2% | 1,240 | 0.0% | 0.10% | +11.7% |
Q2 2021 | $333,000 | -7.8% | 1,240 | -23.7% | 0.09% | -28.8% |
Q4 2020 | $361,000 | -47.1% | 1,625 | -48.7% | 0.13% | -54.9% |
Q3 2020 | $682,000 | -4.9% | 3,166 | -21.9% | 0.29% | -11.5% |
Q2 2020 | $717,000 | +26.0% | 4,056 | +9.3% | 0.33% | +47.8% |
Q4 2019 | $569,000 | +7.0% | 3,710 | +0.7% | 0.22% | -1.8% |
Q3 2019 | $532,000 | +1197.6% | 3,684 | +821.0% | 0.23% | +635.5% |
Q4 2018 | $41,000 | – | 400 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |